ZA889667B - Dopamine-beta-hydroxylase inhibitors - Google Patents

Dopamine-beta-hydroxylase inhibitors

Info

Publication number
ZA889667B
ZA889667B ZA889667A ZA889667A ZA889667B ZA 889667 B ZA889667 B ZA 889667B ZA 889667 A ZA889667 A ZA 889667A ZA 889667 A ZA889667 A ZA 889667A ZA 889667 B ZA889667 B ZA 889667B
Authority
ZA
South Africa
Prior art keywords
dopamine
beta
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
ZA889667A
Other languages
English (en)
Inventor
Lawrence Ivan Kruse
Ivan Kruse Lawrence
Stephen Torey Ross
Torey Ross Stephen
Eliot Howard Ohlstein
Howard Ohlstein Eliot
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA889667B publication Critical patent/ZA889667B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA889667A 1987-12-29 1988-12-28 Dopamine-beta-hydroxylase inhibitors ZA889667B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/138,993 US4935438A (en) 1987-12-29 1987-12-29 Dopamine-β-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
ZA889667B true ZA889667B (en) 1989-12-27

Family

ID=22484635

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA889667A ZA889667B (en) 1987-12-29 1988-12-28 Dopamine-beta-hydroxylase inhibitors

Country Status (6)

Country Link
US (1) US4935438A (xx)
EP (1) EP0323146A3 (xx)
JP (1) JPH03501972A (xx)
AU (1) AU2930689A (xx)
WO (1) WO1989006128A1 (xx)
ZA (1) ZA889667B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900744A (en) * 1988-09-14 1990-02-13 E. I. Du Pont De Nemours And Company Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles
US5030644A (en) * 1989-07-31 1991-07-09 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
CA2022115A1 (en) * 1989-07-31 1991-02-01 David C. Remy Imidazole compounds and their use as transglutaminase inhibitors
US5019572A (en) * 1990-02-07 1991-05-28 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5152988A (en) * 1990-02-07 1992-10-06 Merck & Co., Inc. Imidazole compounds in compositions and methods in thrombolytic therapy
US5183810A (en) * 1990-02-13 1993-02-02 Merck & Co., Inc. Imidazole angiotensin II antagonists incorporating a substituted benzyl element
EP2328879A4 (en) * 2008-09-04 2012-05-09 Ardea Biosciences Inc CORRESPONDING COMPOUNDS, COMPOSITIONS, AND METHODS OF USE FOR MODULATING URIC ACID RATES
EP3971178A1 (en) 2012-03-07 2022-03-23 The McLean Hospital Corporation Aminoquinoline derivatives and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555210A (xx) * 1956-02-23
US3334112A (en) * 1964-05-07 1967-08-01 American Cyanamid Co Aminoalkylenethioimidazoline derivatives
NL6614808A (xx) * 1965-10-21 1967-04-24
DE2259627A1 (de) * 1972-12-06 1974-06-12 Hoechst Ag Imidazolyl-(2)-thio-alkansaeureester und verfahren zu ihrer herstellung
JPS5759871A (en) * 1980-09-29 1982-04-10 Otsuka Pharmaceut Co Ltd Alkanoic acid derivative
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
DE3323870A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
AU2930689A (en) 1989-08-01
JPH03501972A (ja) 1991-05-09
EP0323146A3 (en) 1991-01-30
EP0323146A2 (en) 1989-07-05
WO1989006128A1 (en) 1989-07-13
US4935438A (en) 1990-06-19

Similar Documents

Publication Publication Date Title
PT78388A (en) Dopamine-beta-hydroxylase inhibitors
EP0289506A4 (en) Lipoxygenase inhibitors
ZA884838B (en) Dopamine-beta-hydroxylase inhibitors
ZA883851B (en) Dopamine-beta-hydroxylase inhibitors
PT83076A (en) Dopamine-beta-hydroxylase inhibitors
PT85081A (en) Irreversible dopamine-beta-hydroxylase inhibitors
PT83628B (en) Dopamine-beta-hydroxylase inhibitors
ZA889667B (en) Dopamine-beta-hydroxylase inhibitors
ZA889709B (en) Dopamine-beta-hydroxylase inhibitors
PT84904B (en) Dopamine-beta-hydroxylase inhibitors
ZA8892B (en) Dopamine-beta-hydroxylase inhibitors
ZA882100B (en) Dopamine-beta-hydroxylase inhibitors
ZA876394B (en) Dopamine-beta-hydroxylase inhibitors
AU2911389A (en) 1-aralkyl-2-mercaptoimidazolines as dopamine-beta-hydroxylase inhibitors
PT83626A (en) Dopamine-beta-hydroxylase inhibitors
ZA86949B (en) Dopamine-beta-hydroxylase inhibitors
ZA882275B (en) Dopamine-beta-hydroxylase inhibitors
IE880860L (en) Dopamine-beta-hydroxylase inhibitors
IE882030L (en) Dopamine-beta-hydroxylase inhibitors
IE872276L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
ZA842963B (en) Dopamine-beta-hydroxylase inhibitors
ZW4285A1 (en) Dopamine-beta-hydroxylase inhibitors
ZA842962B (en) Dopamine-beta-hydroxylase inhibitors
GB8810810D0 (en) New use
DE3477926D1 (en) Dopamine-beta-hydroxylase inhibitors